AVITA Medical Issues Warrants for $60M Credit Facility Following Shareholder Approval
RCEL sits 35% above its 52-week low of $3.22.
Summary
AVITA Medical has issued warrants to Perceptive Credit Holdings V, LP, finalizing access to a $60 million credit facility, a crucial financing step following shareholder approval and a recent 'going concern' warning.
Key Events · Financing and Capital Events · RCEL
-
Warrant Issuance Finalized
AVITA Medical issued warrants to Perceptive Credit Holdings V, LP on June 5, 2026, following shareholder approval on June 3, 2026, as previously disclosed.
-
Credit Facility Access
The warrants are tied to a $60 million senior secured credit facility, with an initial $50 million available and a conditional $10 million.
-
Potential Dilution
The warrants are exercisable for up to 650,000 shares at an exercise price of $3.4019 per share, representing approximately 2.19% potential dilution if fully exercised.
-
Addressing Going Concern
This financing is critical for the company, which recently reiterated a 'going concern' warning due to low cash reserves and ongoing operating losses.
Analysis · RCEL · Industrial Applications And Services
This filing formalizes the issuance of warrants to Perceptive Credit Holdings V, LP, enabling the company to access a previously approved $60 million senior secured credit facility. The warrants, exercisable for up to 650,000 shares at $3.4019, are a critical step in securing necessary capital, especially given the company's recent 'going concern' warning. While dilutive, this financing provides essential liquidity and extends the company's operational runway.
At the time of this filing, RCEL was trading at $4.34 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $128.6M. The 52-week trading range was $3.22 to $7.12. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.